Drug Type Unknown |
Synonyms |
Target- |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 2 | US | 22 Nov 2022 | |
Acute Myeloid Leukemia | Discovery | US | 09 Sep 2019 | |
Pervasive child development disorders | Discovery | US | 04 Jan 2018 |